Home / Respiratory system / Salbutamol and Ipratropium Bromide
ATC R03AL02 · Adrenergics in Combination with Anticholinergics incl. Triple Combinations with Corticosteroids
Salbutamol and Ipratropium Bromide shortage
As of 2 Nov 2026, Salbutamol and Ipratropium Bromide has a reported shortage in 3 of the 16 countries we track (Canada, Sweden, New Zealand), covering 3 products from 2 companies.
Countries3/16
Products3packs or presentations
Companies21 listed
Short since10 Mar 20179.6 years ago
Earliest return4 Jan 2027company estimate
Main reasonNot stated
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSweden1 product shortJapanNo reported shortageNew Zealand1 product shortAustraliaNo reported shortage
Timeline
CanadaSwedenNew Zealand
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Orion ORNBV · Nasdaq Helsinki
Compared with similar medicines
ATC group R03AL · Adrenergics in Combination with Anticholinergics incl. Triple Combinations with CorticosteroidsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-SALVENT-IPRAVENT STERULES (5 ML) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| SE | Ipratropium/Salbutamol Orion 0,5 mg/2,5 mg per 2,5 ml Endosbehållare, 60 st (60 x 2,5 ml) anticipated | Orion Corporation | 18 Nov 2026 | 4 Jan 2027 | Not stated |
| NZ | Salbutamol with ipratropium (Duolin) nebuliser | 16 Jan 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.